Get access

Treatment of vulval Crohn's disease with infliximab

Authors


  • Conflict of interest: none declared.

Dr P. W. Preston, Department of Dermatology, Worcestershire Royal Hospital, Charles Hastings Way, Worcester, WR5 1DD, UK. E-mail: pwpreston@doctors.org.uk

Summary

Anti-tumour necrosis factor-α therapy of Crohn's disease (CD) with infliximab has proved a major advance in the treatment of patients with difficult disease. We report our experience of the use of infliximab in a patient with recalcitrant vulval CD. The introduction of infliximab has improved disease control, although a search for an optimum remittive dosing schedule is ongoing.

Ancillary